{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "inhibits_modification",
    "modifications" : [ {
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P12872",
      "entity_text" : "MAP",
      "entity_type" : "protein"
    },
    "is_direct" : false,
    "participant_a" : [ {
      "in_model" : true,
      "identifier" : "uniprot:P62328",
      "entity_text" : "FX",
      "entity_type" : "protein"
    }, {
      "in_model" : true,
      "identifier" : "uniprot:P05362",
      "entity_text" : "ICAM-1",
      "entity_type" : "protein"
    } ],
    "hypothesis_information" : false
  },
  "verbose_text" : "XREF_BIBR XREF_BIBR XREF_BIBR XREF_BIBR - XREF_BIBR The binding of Supartz FX to CD44 and ICAM-1 directly induces MAP kinase phosphatase gene expression, suppresses MAP kinase phosphorylation, inactivates AP-1, and reduces the expression of MMP and ADAMTS in chondrocytes (XREF_FIG and XREF_FIG).",
  "reading_complete" : "2020-08-04T21:59:29Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T21:54:37Z",
  "trigger" : "suppresses",
  "evidence" : [ "FX to CD44 and ICAM-1 directly induces MAP kinase phosphatase gene expression, suppresses MAP kinase phosphorylation" ],
  "pmc_id" : "5724672",
  "score" : 0
}